Funding Opportunity PAR-19-298 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies using non-invasive neurostimulation/neuromodulation in the treatment of Alzheimer's Disease (AD) or Alzheimer's disease-related dementias (ADRD). The goal of this FOA is to establish initial efficacy of neurostimulation/neuromodulation in the treatment of AD/ADRD or to refine these interventions for AD/ADRD patients. Multimodal or combination interventions are allowed, provided the focus and innovative component is neurostimulation.

Funding Opportunity RFA-NS-19-039 from the NIH Guide for Grants and Contracts. (Reissue of RFA-NS-16-021, PAR-18-413) Diffuse brain white matter disease is highly prevalent in the elderly, and has been clinically associated with vascular contributions to cognitive impairment and dementia (VCID) in both men and women. Diffuse white matter disease is thought to include a variety of pathologies including demyelination and/or fiber loss due to multifocal infarction and local ischemia. It is often accompanied by arteriosclerosis in deep penetrating arteries, multiple infarcts in the basal ganglia, brainstem or cerebellum. Though most commonly extending out from the periventricular surfaces, it may also occur in subcortical white matter. Diffuse white matter disease is typically detected in clinical settings as hyperintensity on magnetic resonance imaging (MRI) or signal loss on computed tomography x-ray (CT) scan; diffuse white matter disease can be detected histologically as well, for example in human pathology and in studies using animal models. Despite the prevalence and potential significance of white matter disease for cerebrovascular disease etiology and cognitive outcomes, much remains to be learned about the cellular and molecular causes, regional vulnerability, and progression over time. The physiological consequences of diffuse white matter disease on local axon and neural circuit function are almost completely unknown. The purpose of this FOA is to address some of the many gaps in knowledge of the biologic mechanisms of the commonly occurring, cerebrovascular disease and age-related diffuse white matter disease at the molecular, cellular, tissue and brain circuit level. The ultimate goal of this fundamental research is to inform future efforts to reduce the burden of illness due to age-related vascular contributions to cognitive impairment and dementia.

Competitive Salary: EMBL: Project Manager - Heidelberg Center for Human Bioinformatics (HD-HuB) Germany (DE)

Negotiable: SRG: Bioinformatics Scientist - Image Analysis/ Data ScientistRole Type: PermanentSalary: DOE- from £32KWork Area: Computational ScienceGlobal Biotechnolog Cambridge, England

Notice NOT-OD-19-107 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-ES-19-010 from the NIH Guide for Grants and Contracts. The goal of this NIEHS undergraduate research education R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce in the environmental health sciences. To this end, this funding opportunity announcement (FOA) encourages the development of creative educational activities with a primary focus on research experiences for undergraduates at the junior and senior level.

Funding Opportunity RFA-AG-20-007 from the NIH Guide for Grants and Contracts. The primary aim of this Funding Opportunity Announcement (FOA) is to facilitate the characterization of the marmoset as a laboratory animal for research on aging and age-related diseases.

Skills in bioinformatics, ruminal microbial techniques, and statistical analysis are preferred. The qualified candidate must have received a doctorate degree in... $5,185 a month
From Oak Ridge Associated Universities - Thu, 13 Jun 2019 20:16:52 GMT - View all Madison, WI jobs

Master’s Degree plus a minimum of six years of industry work experience or a PhD Degree in a quantitative discipline (e.g., statistics, operations research,…
From Schneider - Thu, 13 Jun 2019 17:36:38 GMT - View all Green Bay, WI jobs

PhD Degree in a quantitative discipline (e.g., statistics, operations research, bioinformatics, economics, computational biology, computer science, mathematics,...
From Schneider - Thu, 13 Jun 2019 17:36:38 GMT - View all Green Bay, WI jobs

Master’s Degree plus a minimum of six years of industry work experience or a PhD Degree in a quantitative discipline (e.g., statistics, operations research,…
From Schneider National - Thu, 13 Jun 2019 16:52:28 GMT - View all Green Bay, WI jobs

PhD Degree in a quantitative discipline (e.g., statistics, operations research, bioinformatics, economics, computational biology, computer science, mathematics,...
From Schneider National - Thu, 13 Jun 2019 16:52:28 GMT - View all Green Bay, WI jobs

F. Hoffmann-La Roche AG: We are looking for a motivated biostatistician to quickly integrate into and complement an existing team of data analysis experts in the Pharma Switzerland (CH)

Funding Opportunity RFA-TR-19-014 from the NIH Guide for Grants and Contracts. This FOA invites applications for projects designed to test the effectiveness of microphysiological systems (MPS), also called tissue chip, technology, for clinical trial frameworks by demonstrating their applied use in clinical trial planning and execution, addressing both safety and efficacy in late-stage preclinical studies. This approach is to provide evidence of the utility of tissue chip technology for precision medicine in informing trial design, establishing recruitment criteria and stratification of patient populations in identifying the best responders to candidate therapeutics.

Salary Depends on Experience: Dana-Farber Cancer Institute: Seeking candidates for a Postdoctoral Postion in Gabuzda Laboratory at DFCI. Systems biology experience is helpful. Boston, Massachusetts (US)

Notice NOT-MH-20-022 from the NIH Guide for Grants and Contracts

Notice NOT-NS-19-058 from the NIH Guide for Grants and Contracts

Notice NOT-NS-19-068 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-20-215 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Institute of Mental Health (NIMH) seeks applications to develop, sustain, enhance, and enrich a centralized national biorepository for genetic studies of psychiatric disorders for facilitation and acceleration of the scientific understanding of the genetic risk architecture underlying mental disorders. This effort is expected to involve a functionally integrated, multi-disciplinary team that will provide for open sharing of biosamples and data resources through a single, centralized, national resource to advance basic and translational research in the genetics of mental disorders.

Funding Opportunity RFA-AG-20-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to conduct new research on automobile technology for signaling early signs of cognitive impairment in older drivers.